CYDEX, INC.
🏢 View company profile →5Patents
0Active
5Granted
31Portfolio score
Filing activity: May 5, 1997 → May 4, 2002
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6046177A | Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations | Performing Operations; Transporting | 230 | Expired |
| US5874418A | Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use | Human Necessities | 209 | Expired |
| US6133248A | Polar drug of prodrug compositions with extended shelf-life storage and a method of making thereof | Human Necessities | 140 | Expired |
| US7034013B2 | Formulations containing propofol and a sulfoalkyl ether cyclodextrin | Emerging Cross-Sectional Technologies | 67 | Expired |
| US6869939B2 | Formulations containing amiodarone and sulfoalkyl ether cyclodextrin | Human Necessities | 20 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.